Search Results 571-580 of 17177 for Alkaptonuria

  1. Pediatrics Clinical Trials - Medical Professionals

    Find pediatric clinical trials at your nearest Mayo Clinic location.

  2. Clinical trials - Oncology (Medical)

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

  3. Amyloidosis - Doctors and departments - Mayo Clinic

    This rare disease caused by a buildup of the protein amyloid can affect different organs in different people. Find out how early and accurate diagnosis can ...

  4. Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis - Mayo Clinic

    The purpose of this study is to test the hypothesis that benralizumab will reduce exacerbation rates compared with placebo on top of standard-of-care therapy in ...

  5. The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial. - Mayo Clinic

    Those using antihypertensive or antiarrhythmic agents; Those with significant cardiopulmonary comorbidities (namely history of arrhythmia, coronary artery ...

  6. General Internal Medicine - Clinical trials

    The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...

  7. Effects of Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites - Mayo Clinic

    This is a phase 3, multicenter, randomized, controlled, parallel-group, and open-label clinical study to evaluate the efficacy of standard medical treatment ( ...

  8. CardiolRx In Recurrent Pericarditis Following IL-1 Blocker Cessation - Mayo Clinic

    About this study. Multi-center, randomized, double-blind, placebo-controlled, phase-3 Trial. Patients with a history of recurrent pericarditis who are being ...

  9. Tuberculosis - Doctors and departments - Mayo Clinic

    Learn about the prevention and treatment of this disease that causes serious illness around the world.

  10. A Phase 1 Dose Escalation and Expansion Study of TGR-1202 + Ruxolitinib in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (PPV-MF), Post-Essential Thrombocythemia MF (PET-MF), MDS/MPN, or Polycythemia Vera Resistant to Hydroxyurea - Mayo Clinic

    A Phase 1 Dose Escalation and Expansion Study of TGR-1202 + Ruxolitinib in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (PPV-MF), ...